慢性全闭塞的临床数据的更新 皮肤穿冠状动脉干预
Alexander E Sullivan1, Noah N Williford2, Emmanouil S Brilakis3
1Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Interventional cardiology clinics
|November 23, 2025
概括
慢性全封闭 (CTO) 穿皮冠状动脉干预 (PCI) 的进展提高了成功率,并减少了并发症. 新数据显示,CTO PCI还可以增强左心室功能,减少缺血负担.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
背景情况:
- 慢性全遮 (CTO) 穿皮冠状动脉干预 (PCI) 技术和设备在过去20年里有了显著的进化.
- 这些进步带来了改善的程序结果,包括更高的成功率,缩短的程序时间,减少了辐射和对比剂的使用.
研究的目的:
- 探索CTO PCI的最新进展.
- 讨论CTO PCI除了减轻症状之外的扩大好处,包括心脏功能和心肌缺血的改善.
主要方法:
- 关于CTO PCI的最新数据和文献的审查.
- 探索干预心脏病学中不断发展的技术和设备.
主要成果:
- CTO PCI的成功率有所增加.
- 手术的持续时间,辐射暴露和对比度使用都减少了.
- 现在的好处包括左心室功能恢复和减少缺血负担.
结论:
- 现代CTO PCI更安全,更有效.
- CTO PCI的治疗效果延伸到显著的心脏功能和缺血改善.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
329
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
329
Acute Coronary Syndrome I: Introduction
744
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
744
Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
330
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
330


